학술논문
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
Document Type
Article
Author
Source
JAMA Ophthalmology; Sep2023, Vol. 141 Issue 9, p834-842, 9p
Subject
Language
ISSN
21686165